What is Wedbush’s Estimate for APLS FY2029 Earnings?
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush lifted their FY2029 EPS estimates for shares of Apellis Pharmaceuticals in a note issued to investors on Monday, March 3rd. Wedbush analyst L. Chico now anticipates that the company will earn $3.79 per share for the year, up from their prior estimate of […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush lifted their FY2029 EPS estimates for shares of Apellis Pharmaceuticals in a note issued to investors on Monday, March 3rd. Wedbush analyst L. Chico now anticipates that the company will earn $3.79 per share for the year, up from their prior estimate of […]
